Model-Based Glycaemic Control in Multicentre ICUs within Diabetic Patients: In-silico Analysis
Sliding-scale insulin therapy has been vastly used for glycaemic control but dysglycaemia remains high. Model-based glycaemic control that incorporates insulin nutrition protocol was proposed as this therapy provides personalized care to avoid dysglycaemia. Thus, this paper aims to implement in-sili...
Saved in:
Main Authors: | , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Penerbit UTHM
2025
|
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.uniten.dspace-36985 |
---|---|
record_format |
dspace |
spelling |
my.uniten.dspace-369852025-03-03T15:46:21Z Model-Based Glycaemic Control in Multicentre ICUs within Diabetic Patients: In-silico Analysis Razak A.A. Razak N. Shah N.N.H. Abu-Samah A. Jamaludin U. Suhaimi F. 56960052400 37059587300 7401823793 56719596600 55330889600 36247893200 Sliding-scale insulin therapy has been vastly used for glycaemic control but dysglycaemia remains high. Model-based glycaemic control that incorporates insulin nutrition protocol was proposed as this therapy provides personalized care to avoid dysglycaemia. Thus, this paper aims to implement in-silico simulation and identify which model-based control protocols yield better protocol within ICU diabetic patients based on performance and safety. Multicentre ICU patients of 282 were divided into diabetes mellitus (DM) and non-diabetes mellitus (NDM) cohort where in-silico simulations were done using Specialised Relative Insulin Nutrition Therapy (SPRINT), SPRINT+Glargine and Stochastic Targeted (STAR) protocols. Performance was verified based on the percentage of blood glucose (BG) time in band (TIB) 6.0 ? 10.0 mmol/L and safety with number of mild and severe hypoglycaemia episodes. Among the three protocols, STAR protocol showed the highest median and interquartile range % BG TIB 6.0 ? 10.0 mmol/L for DM and NDM patients with 71.6 % [57.9 ? 79.8] and 77.4 % [62.9 ? 88.8]. The number of hypoglycaemia episodes are the lowest in DM and NDM patients too compared to other protocols. These advantages show that STAR protocol can provide better patient outcomes for glycaemic control with personalized care. ? This is an open access article under the CC BY-NC-SA 4.0 license Final 2025-03-03T07:46:21Z 2025-03-03T07:46:21Z 2024 Article 10.30880/ijie.2024.16.03.007 2-s2.0-85195308767 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195308767&doi=10.30880%2fijie.2024.16.03.007&partnerID=40&md5=5f30593aeab2f5a60c4a5a8445af5bc8 https://irepository.uniten.edu.my/handle/123456789/36985 16 3 67 77 Penerbit UTHM Scopus |
institution |
Universiti Tenaga Nasional |
building |
UNITEN Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Tenaga Nasional |
content_source |
UNITEN Institutional Repository |
url_provider |
http://dspace.uniten.edu.my/ |
description |
Sliding-scale insulin therapy has been vastly used for glycaemic control but dysglycaemia remains high. Model-based glycaemic control that incorporates insulin nutrition protocol was proposed as this therapy provides personalized care to avoid dysglycaemia. Thus, this paper aims to implement in-silico simulation and identify which model-based control protocols yield better protocol within ICU diabetic patients based on performance and safety. Multicentre ICU patients of 282 were divided into diabetes mellitus (DM) and non-diabetes mellitus (NDM) cohort where in-silico simulations were done using Specialised Relative Insulin Nutrition Therapy (SPRINT), SPRINT+Glargine and Stochastic Targeted (STAR) protocols. Performance was verified based on the percentage of blood glucose (BG) time in band (TIB) 6.0 ? 10.0 mmol/L and safety with number of mild and severe hypoglycaemia episodes. Among the three protocols, STAR protocol showed the highest median and interquartile range % BG TIB 6.0 ? 10.0 mmol/L for DM and NDM patients with 71.6 % [57.9 ? 79.8] and 77.4 % [62.9 ? 88.8]. The number of hypoglycaemia episodes are the lowest in DM and NDM patients too compared to other protocols. These advantages show that STAR protocol can provide better patient outcomes for glycaemic control with personalized care. ? This is an open access article under the CC BY-NC-SA 4.0 license |
author2 |
56960052400 |
author_facet |
56960052400 Razak A.A. Razak N. Shah N.N.H. Abu-Samah A. Jamaludin U. Suhaimi F. |
format |
Article |
author |
Razak A.A. Razak N. Shah N.N.H. Abu-Samah A. Jamaludin U. Suhaimi F. |
spellingShingle |
Razak A.A. Razak N. Shah N.N.H. Abu-Samah A. Jamaludin U. Suhaimi F. Model-Based Glycaemic Control in Multicentre ICUs within Diabetic Patients: In-silico Analysis |
author_sort |
Razak A.A. |
title |
Model-Based Glycaemic Control in Multicentre ICUs within Diabetic Patients: In-silico Analysis |
title_short |
Model-Based Glycaemic Control in Multicentre ICUs within Diabetic Patients: In-silico Analysis |
title_full |
Model-Based Glycaemic Control in Multicentre ICUs within Diabetic Patients: In-silico Analysis |
title_fullStr |
Model-Based Glycaemic Control in Multicentre ICUs within Diabetic Patients: In-silico Analysis |
title_full_unstemmed |
Model-Based Glycaemic Control in Multicentre ICUs within Diabetic Patients: In-silico Analysis |
title_sort |
model-based glycaemic control in multicentre icus within diabetic patients: in-silico analysis |
publisher |
Penerbit UTHM |
publishDate |
2025 |
_version_ |
1825816124688695296 |
score |
13.244413 |